You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

Details for Patent: 4,962,128


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 4,962,128
Title: Method of treating anxiety-related disorders using sertraline
Abstract:A method of treating anxiety-related disorders comprising administering to a human in need of such treatment an amount of the compound (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenam ine also known by the generic name sertraline, or a pharmaceutically acceptable salt thereof, effective in preventing or alleviating anxiety and the symptoms associated with anxiety-related disorders.
Inventor(s): Doogan; Declan P. (Canterbury, GB2), Scappaticci; Karen A. (New York, NY), Hackett; Elizabeth (New York, NY)
Assignee: Pfizer Inc. (New York, NY)
Application Number:07/431,000
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 4,962,128

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 4,962,128

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 212223 ⤷  Try a Trial
Austria 269068 ⤷  Try a Trial
Austria 327743 ⤷  Try a Trial
Australia 616127 ⤷  Try a Trial
Australia 6571590 ⤷  Try a Trial
Canada 2029065 ⤷  Try a Trial
Germany 69033903 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.